Shiba Inu Burn Rate Surge 24,271% While Shibarium Transactions Spike, Catalyst For Rally To $0.00008?November 3, 2024
Business Bristol Myers’ HCC Combo Drug Accepted for FDA Review – Bristol-Myers Squibb (NYSE:BMY)By adminAugust 22, 2024 Bristol Myers BMY announced that the FDA has accepted its supplemental Biologics License Application (sBLA) for the immunotherapy drug, Opdivo…
